Paper Details
- Home
- Paper Details
Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease.
Author: Marti-CarvajalA J, Pérez-RequejoJ L
Original Abstract of the Article :
Upper gastrointestinal bleeding is one of the most frequent causes of morbidity and mortality in the course of liver cirrhosis. Patients with liver disease frequently have haemostatic abnormalities, which include accelerated fibrinolysis. Several primary treatments are used for upper gastrointestina...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1002/14651858.CD006007.pub2
データ提供:米国国立医学図書館(NLM)
Antifibrinolytic Amino Acids: A Potential Solution for Acquired Coagulation Disorders in Liver Disease
Liver disease creates a complex landscape of health challenges, often leading to acquired coagulation disorders and serious complications. This research explores the potential of antifibrinolytic amino acids as a therapeutic intervention in patients with liver disease. This study, like a search for a rare medicinal herb in the desert, explores a potential treatment for this challenging condition.
Antifibrinolytic Amino Acids: A Promising Approach to Managing Coagulation Disorders
The study suggests that antifibrinolytic amino acids may offer a potential solution for managing acquired coagulation disorders in patients with liver disease. While further research is needed, this finding provides a promising avenue for addressing this critical health issue. This research is like discovering a hidden spring in the desert, providing potential relief and hope for patients struggling with coagulation disorders.
Antifibrinolytic Amino Acids: A Promising Approach to Managing Coagulation Disorders
This study, much like a guide leading through the desert, offers a potential path for improving the management of liver disease. It provides valuable insights into the potential of antifibrinolytic amino acids, offering a glimmer of hope for patients facing this challenging condition.
Dr.Camel's Conclusion
This study provides a valuable insight into the potential of antifibrinolytic amino acids in managing acquired coagulation disorders in liver disease. This research, like finding a precious gem in the vast desert, offers a glimmer of hope in the search for effective treatment options for this challenging condition.
Date :
- Date Completed 2007-05-08
- Date Revised 2018-12-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.